Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00996411 · ClinicalTrials.gov registry record · Phase 1
Human Psychopharmacology of Salvinorin A
A Phase 1 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
NCT00996411: Completed Phase 1 study, sponsored by Johns Hopkins University.
NCT00996411 is a Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00996411, a Phase 1 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
Study Summary
This study is characterizing the subject-rated and behavioral effects of salvinorin A in healthy volunteers. The investigators hypothesize the salvinorin A will have hallucinogen-like effects.
Interventions
- DRUG Salvinorin A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2008-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00996411
The ClinicalTrials.gov registry entry for NCT00996411 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Salvinorin A is the first listed.
NCT00996411 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00996411 about?
NCT00996411 is a clinical study titled "Human Psychopharmacology of Salvinorin A". This study is characterizing the subject-rated and behavioral effects of salvinorin A in healthy volunteers. The investigators hypothesize the salvinorin A will have hallucinogen-like effects.
What is the current status of trial NCT00996411?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2008-11.
What interventions are being tested in trial NCT00996411?
The interventions under investigation include: Salvinorin A (DRUG).
Who is sponsoring clinical trial NCT00996411?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.